News

Scientists at The Scripps Research Institute have devised what they call a “neuronal cookbook” for turning skin cells into different types of neurons.

Floyd Romesberg, PhD, professor at The Scripps Research Institute, has won the 2018 Royal Society of Chemistry (RSC) Bioorganic Chemistry Award.

Scientists at Calibr and Scripps Research have discovered how a potential new drug targets this deadly disease.

A neuroscientist explores the root of plasticity in the brain.

"We have a great team here at Scripps Research for rational design of vaccines."

Scripps Translational Science Institute to lead the national Participant Center and the program’s use of mobile technologies for each individual to collect their health data.

“Scripps Research is one of the only places in the world where you can do this type of large-scale behavioral study..."

"We are thrilled to have the NIH’s continued support for our efforts to advance individualized medicine, both in care of patients and in training of young physicians and scientists."

Scientists have identified a protein, called GPR68, that senses blood flow and tells small blood vessels called arterioles when to dilate. 

Researchers found a transcription factor protein called Runx3 puts dividing T cells on track to becoming memory T cells. 

“There is a dire need for the development of new, effective and safe therapies against chronic lymphocytic leukemia.”

A new discovery by Scripps Research scientists may offer insight into treating blood disorders such as sickle cell anemia.

Scripps Research scientists uncover role of key protein in genetic disease Charcot-Marie-Tooth with public support.

Balzan Prize and Coley Award goes to former Scripps Research postdocs.

Influenza kills thousands of Americans each year. Now a new study shows how we could improve flu vaccines.

"We need to know what is happening in the brain so that we can develop more efficient therapies."

This is the 19th year in a row that the program has earned top ten honors.

A surprising common mutation may have evolved to protect humans from malaria.

Researchers have discovered a pathway in cells that promotes mitochondrial function during times of stress, a response that can guard against disease as we age.

Calibr has now identified and repurposed an FDA-approved drug, clofazimine, used for decades to treat leprosy, as a potential new treatment for cryptosporidiosis.

"It’s already clear that this method opens the door to creating new types of compounds and new types of bonds."

"This study provides guidance for developing therapeutics," says Xiang-Lei Yang, PhD, TSRI professor and senior author of the study.

The new study offers an explanation for why neurons die off in the first place.